文献速递神经MR

1.5 T 脑成像中三维运动校正(通过 Scout 加速运动估计与减少框架)与常规 T1 加权 MRI 的临床评估

Clinical Evaluation of 3D Motion-Correction Via Scout Accelerated Motion Estimation and Reduction Framework Versus Conventional T1-Weighted MRI at 1.5 T in Brain Imaging.
PubMed 文献 · Invest Radiol · 2025-01-22

本研究在 1.5 T 脑 MRI 中比较三维运动校正 SAMER 框架与常规重建的 T1 加权图像质量,纳入 14 名健康志愿者和 82 例患者,发现 SAMER 运动校正可显著提高图像质量、减少运动伪影并提升诊断信心。

要点

  • SAMER 运动校正可显著减少 1.5 T 脑 T1 加权图像的运动伪影。
  • 患者研究中 SAMER 运动校正的诊断信心优良率为 95.1%,常规重建为 78.1%。
  • SAMER 运动校正的图像质量优良率为 89.8%,常规重建为 65.9%。

核心结论

  • 在 1.5 T 脑 MRI 的 T1 加权成像中应用 SAMER 运动校正可行,能有效减少运动伪影并显著提高图像质量和诊断信心。

研究设计与样本

  • 初步研究纳入 14 名健康志愿者,在 3 T MRI 扫描中诱导 3 种运动模式;患者研究纳入 82 例临床需行 MRI 检查的患者,在 1.5 T 下采集三维 T1 加权图像(MPRAGE),分别用常规产品重建(非运动校正)或三维运动校正 SAMER 框架重建,共获得 145 个图像序列,由 3 名经验丰富的放射科医生采用 5 分 Likert 量表评估。

关键影像表现/征象

  • 初步研究中 SAMER 运动校正较非运动校正显著改善所有成像参数和运动模式(P < 0.001)。
  • 患者研究中 SAMER 运动校正较非运动校正在所有评估参数上均显著提高图像质量,尤其在存在运动时(P < 0.001)。

诊断标准与关键数值

  • 初步研究中 SAMER 运动校正的无伪影和整体图像质量的比值比均 >999.999(P < 0.0001),均支持 SAMER 运动校正。
  • 初步研究中无伪影评级的优良率:SAMER 运动校正为 52.4%,非运动校正为 21.4%。
  • 初步研究中整体图像质量评级的优良率:SAMER 运动校正为 66.7%,非运动校正为 21.4%。
  • 患者研究中诊断信心评级的优良率:SAMER 运动校正为 95.1%,非运动校正为 78.1%。
  • 患者研究中整体图像质量评级的优良率:SAMER 运动校正为 89.8%,非运动校正为 65.9%;诊断信心和整体图像质量的比值比分别为 6.698 和 6.030(P < 0.0001),均支持 SAMER 运动校正。

临床应用与阅片要点

  • 在 1.5 T 脑 T1 加权成像中,SAMER 运动校正可有效减少运动伪影,提高图像质量和诊断信心。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to investigate the occurrence of motion artifacts and image quality of brain magnetic resonance imaging (MRI) T1-weighted imaging applying 3D motion correction via the Scout Accelerated Motion Estimation and Reduction (SAMER) framework compared with conventional T1-weighted imaging at 1.5 T.

MATERIALS AND METHODS: A preliminary study involving 14 healthy volunteers assessed the impact of the SAMER framework on induced motion during 3 T MRI scans. Participants performed 3 different motion patterns: (1) step up, (2) controlled breathing, and (3) free motion. The patient study included 82 patients who required clinically indicated MRI scans. 3D T1-weighted images (MPRAGE) were acquired at 1.5 T. The MRI data were reconstructed using either regular product reconstruction (non-Moco) or the 3D motion correction SAMER framework (SAMER Moco), resulting in 145 image sequences. For the preliminary and the patient study, 3 experienced radiologists evaluated the image data using a 5-point Likert scale, focusing on overall image quality, artifact presence, diagnostic confidence, delineation of pathology, and image sharpness. Interrater agreement was assessed using Gwet's AC 2 , and an exploratory analysis (non-Moco vs SAMER Moco) was performed.

RESULTS: Compared with non-Moco, the preliminary study demonstrated significant improvements across all imaging parameters and motion patterns with SAMER Moco ( P < 0.001). Odds ratios favoring SAMER Moco were >999.999 for freedom of artifact and overall image quality ( P < 0.0001). Excellent or good ratings for freedom of artifact were 52.4% with SAMER Moco, compared with 21.4% for non-Moco. Similarly, 66.7% of SAMER Moco images were rated excellent or good for overall image quality versus 21.4% for non-Moco. Multireader interrater agreement was excellent across all parameters.The patient study confirmed that SAMER Moco provided significantly superior image quality across all evaluated imaging parameters, particularly in the presence of motion ( P < 0.001). Diagnostic confidence was rated as excellent or good in 95.1% of SAMER Moco cases, compared with 78.1% for non-Moco cases. Similarly, overall image quality was rated as excellent or good in 89.8% of SAMER Moco cases versus 65.9% for non-Moco cases. The odds ratios for diagnostic confidence and for overall image quality were 6.698 and 6.030, respectively, both favoring SAMER Moco ( P < 0.0001). Multireader interrater agreement was excellent across all parameters.

CONCLUSIONS: The application of SAMER in T1-weighted imaging datasets is feasible in clinical routine and significantly increases image quality and diagnostic confidence in 1.5 T brain MRI by effectively reducing motion artifacts.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Leukert LS, Heitkötter KH, Kronfeld A, et al. Clinical Evaluation of 3D Motion-Correction Via Scout Accelerated Motion Estimation and Reduction Framework Versus Conventional T1-Weighted MRI at 1.5 T in Brain Imaging. Invest Radiol. 2025. PMID: 39841594. doi:10.1097/RLI.0000000000001156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。